St. James Therapeutics Inc. — Form D
St. James Therapeutics Inc. of AKRON, OH, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-14. The offering totals $850K, of which $350K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-11-14
- Form: D
- Accession: 0002000945-23-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $850K
- Amount sold: $350K
- Remaining: $500K
- Minimum investment: $50K
- Investors: 7
- Date of first sale: 2023-08-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-497203
Issuer
- Name: St. James Therapeutics Inc.
- CIK: 0002000945
- Entity type: Corporation
- Jurisdiction: OHIO
- Incorporated: 2018
- Address: 2046 AKRON PENINSULA ROAD, AKRON, OH, 44313
- Phone: 330-208-6388
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Mark Allio | Director | Akron, OH |
| Michael Allio | Director | Akron, OH |
| Michele Allio | Director | Akron, OH |
| Mark Allio | Executive Officer | Akron, OH |
| Michael Allio | Executive Officer | Akron, OH |
More